Nasdaq:US$13.41 (-0.23) | HKEX:HK$21.20 (+0.05) | AIM:£2.15 (-0.07)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 30 Nov 2010

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)